glp-1 and hypertension receptor agonists (GLP-1RAs): cardiovascular actions therapeutic potential GLP-1 Hypertension: A New Edge

These two antioxidants combined have been found to slow down the aging process, protect the skin from UV rays and pollutants, while also managing inflammation and lipid peroxidation

Not surprisingly, the authors found that glucagon increases the response to sweet stimuli in mice [138]

00:07:27 Vickie Danaher For example, oral semaglutide for obesity is also approved to reduce the risk of cardiovascular events, such as stroke or heart attacks, in patients with CV disease and obesity

It claims that people typically lose 10% to 20% of their weight with support from a GLP-1

What the science says: Theres no clinical evidence that kisspeptin-10 can reverse menopause. Theres also no evidence that it has an effect on brain fog

PMID: 12459848